Processa Pharmaceuticals (PCSA) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free PCSA Stock Alerts $2.48 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineProcessa Pharmaceuticals to Participate in the EF Hutton Annual Global Conferenceglobenewswire.com - May 6 at 8:00 AMProcessa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Researchglobenewswire.com - April 30 at 8:00 AMProcessa Pharmaceuticals, Inc. to Post Q1 2024 Earnings of ($1.18) Per Share, HC Wainwright Forecasts (NASDAQ:PCSA)americanbankingnews.com - April 29 at 1:24 AMHC Wainwright & Co. Initiates Coverage of Processa Pharmaceuticals (PCSA) with Buy Recommendationmsn.com - April 26 at 9:48 AMU.S. shares lower at close of trade; Dow Jones Industrial Average down 1.09%msn.com - April 11 at 11:40 PMProcessa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trialfinance.yahoo.com - April 11 at 8:39 AMInsider Buyers At Processa Pharmaceuticals Recover Some Losses, But Still Down US$40kfinance.yahoo.com - April 7 at 11:17 AMEva Mendes says she had 'non-verbal agreement' with Ryan Gosling to be a stay-at-home momnz.finance.yahoo.com - March 28 at 11:53 AMProcessa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conferenceglobenewswire.com - March 28 at 8:15 AMProcessa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meetingglobenewswire.com - March 25 at 8:15 AMProcessa Pharmaceuticals (PCSA) Price Target Increased by 1900.00% to 81.60msn.com - February 24 at 3:05 PMProcessa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conferencefinance.yahoo.com - February 21 at 9:33 AMProcessa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conferenceglobenewswire.com - February 21 at 8:15 AMProcessa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conferencefinance.yahoo.com - February 14 at 6:02 PMProcessa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conferenceglobenewswire.com - February 14 at 1:00 PMProcessa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rulemarkets.businessinsider.com - February 6 at 2:44 PMProcessa Pharmaceuticals Inc (PCSA)investing.com - February 6 at 2:01 AMProcessa Pharmaceuticals Announces Closing of $7.0 Million Public Offeringfinance.yahoo.com - February 1 at 7:49 PMProcessa Pharmaceuticals Announces Offering Pricing Detailsmsn.com - February 1 at 12:03 AMProcessa Pharmaceuticals Shares Drop 24% After Pricing Offeringmarketwatch.com - January 27 at 11:57 PMProcessa Pharmaceuticals prices discounted stock and warrants offering to raise $7Mmsn.com - January 26 at 6:25 PMWhat's Going On With Anti Cancer Focused Processa Pharmaceuticals Stock Today?msn.com - January 26 at 6:25 PMProcessa Pharmaceuticals Announces Pricing of $7.0 Million Public Offeringfinance.yahoo.com - January 26 at 6:25 PMProcessa Pharmaceuticals Shares More Than Double After Completing Safety Evaluation of Cancer Treatmentmarketwatch.com - January 25 at 10:17 AMProcessa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Dosesfinance.yahoo.com - January 25 at 10:17 AMmarketbeat.com - January 25 at 9:58 AMmarketbeat.com - January 22 at 6:00 AMProcessa Pharmaceuticals Expands NGC-Cap Cancer Programmsn.com - January 20 at 9:26 AMProcessa Pharmaceuticals, Inc.: Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancerfinanznachrichten.de - January 19 at 12:58 PMWhy Processa Pharmaceuticals (PCSA) Stock Is Skyrocketingmsn.com - January 19 at 12:58 PMProcessa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancerfinance.yahoo.com - January 19 at 7:58 AMProcessa Pharmaceuticals, Inc.: Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Splitfinanznachrichten.de - January 18 at 3:01 PMWhy Processa Pharmaceuticals (PCSA) Shares Are Nosedivingmsn.com - January 18 at 3:01 PMProcessa Pharmaceuticals to effect 1-for-20 reverse stock split to regain compliance with Nasdaq rulemsn.com - January 18 at 10:01 AMProcessa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Splitfinance.yahoo.com - January 18 at 10:01 AMProcessa Pharmaceuticals to Present at the Biotech Showcase 2024finance.yahoo.com - January 2 at 6:53 PMProcessa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabinefinance.yahoo.com - December 19 at 9:43 AMWhat's Going On With Processa Pharmaceuticals (PCSA) Stock?msn.com - December 13 at 12:15 PMIs Processa Pharmaceuticals (NASDAQ:PCSA) In A Good Position To Invest In Growth?finance.yahoo.com - December 12 at 9:36 AMProcessa Pharmaceuticals to Present at the MedInvest Oncology Investor Conferencefinance.yahoo.com - November 30 at 8:32 AMProcessa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlookfinance.yahoo.com - November 29 at 9:18 AMProcessa Pharmaceuticals Inc PCSAmorningstar.com - November 21 at 3:30 PMMaxim Group Downgrades Processa Pharmaceuticals (PCSA)msn.com - November 18 at 7:47 AMProcessa Pharmaceuticals downgraded to Hold from Buy at Maximrealmoney.thestreet.com - November 17 at 9:31 AMProcessa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil Thompsonfinance.yahoo.com - November 13 at 3:23 PMProcessa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americasfinance.yahoo.com - November 9 at 1:18 PMProcessa Pharmaceuticals Inc.barrons.com - September 17 at 12:42 PMProcessa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 9:22 AMProcessa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer Carefinance.yahoo.com - August 17 at 9:44 AMSidoti Events, LLC’s Virtual August Micro-Cap Conferencefinance.yahoo.com - August 15 at 10:31 AM Get Processa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter. Email Address BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad)BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it. Discover the name and ticker of this $2 stock here >>> PCSA Media Mentions By Week PCSA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCSA News Sentiment▼0.550.36▲Average Medical News Sentiment PCSA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCSA Articles This Week▼11▲PCSA Articles Average Week Get Processa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ainos News Kineta News Protagenic Therapeutics News Hillstream BioPharma News Kintara Therapeutics News Lixte Biotechnology News Hoth Therapeutics News Xenetic Biosciences News Shuttle Pharmaceuticals News Enveric Biosciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCSA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
